In transformed breast cells, IL-6 reduces the expression levels of let-7 by activating Lin28 transcription via the NF-κB pathway, leading to the development of breast cancer and enhanced CSC characteristics (Iliopoulos et al., 2009; Shyh-Chang and Daley, 2013). Here, IL6 is linked to breast carcinoma.